NASDAQ: IPODDune Acquisition Corp II Stock
$10.19+0.00 (+0%)
Updated Dec 16, 2025
IPOD Price
$10.19
Fair Value Price
N/A
Market Cap
$206.17M
52 Week Low
$10.00
52 Week High
$10.25
P/E
101.9x
P/B
-38.55x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$2.01M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.09
Operating Cash Flow
-$423k
Beta
0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
IPOD Overview
Dune Acquisition Corporation II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on software as a service, artificial intelligence, medtech, asset management, and consultancy sectors. The company was incorporated in 2024 and is based in West Palm Beach, Florida.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine IPOD's potential to beat the market
- IPOD doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
IPOD
RankedUnranked of 30
RankedUnranked of 30
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.91 | C | |
| $10.23 | C | |
| $9.90 | C |
Be the first to know about important IPOD news, forecast changes, insider trades & much more!
IPOD News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IPOD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IPOD is poor value based on its earnings relative to its share price (101.9x), compared to the US market average (45.32x)
P/E vs Market Valuation
IPOD is poor value based on its earnings relative to its share price (101.9x), compared to the US Shell Companies industry average (11.91x)
P/E vs Industry Valuation
IPOD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more IPOD due diligence checks available for Premium users.
Valuation
IPOD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
101.9x
Industry
11.91x
Market
45.32x
IPOD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IPOD is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
IPOD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-38.55x
Industry
-53.58x
IPOD's financial health
Profit margin
Revenue
$0.0
Net Income
$1.3M
Profit Margin
0%
IPOD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$147.0M
Liabilities
$5.8M
Debt to equity
-1.09
IPOD's short-term assets ($478.04k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IPOD's long-term liabilities ($5.75M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IPOD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IPOD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$187.9k
Investing
$0.0
Financing
$0.0
IPOD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
IPOD vs Shell Company Stocks
Dune Acquisition II Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.